$KITT
Nauticus Robotics, Inc.

2021 Q2 Form 10-Q Financial Statement

#000121390021045892 Filed on August 31, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q4 2020 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $1.463M
YoY Change
Gross Profit -$1.463M
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00
YoY Change
% of Gross Profit
Research & Development $466.8K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $0.00
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $609.9K
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 3.750M shares
Diluted Shares Outstanding 3.750M shares

Balance Sheet

Concept 2021 Q2 2020 Q4 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.00K
YoY Change
Cash & Equivalents $25.00K $25.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.00K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $221.9K
YoY Change
Total Long-Term Assets $221.9K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $25.00K
Total Long-Term Assets $221.9K
Total Assets $246.9K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $40.07K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $182.9K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $222.9K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $222.9K
Total Long-Term Liabilities $0.00
Total Liabilities $222.9K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $431.00 $431.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.00K $24.00K
YoY Change
Total Liabilities & Shareholders Equity $246.9K
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q4 2020 Q2
OPERATING ACTIVITIES
Net Income
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 0.000
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
431 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
431 USD
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3750000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3750000 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3750000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
dei Entity Central Index Key
EntityCentralIndexKey
0001849820
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
USD
us-gaap Net Income Loss
NetIncomeLoss
USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2020Q2 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
USD
CY2020Q2 claqu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
USD

Files In Submission

Name View Source Status
0001213900-21-045892-index-headers.html Edgar Link pending
0001213900-21-045892-index.html Edgar Link pending
0001213900-21-045892.txt Edgar Link pending
0001213900-21-045892-xbrl.zip Edgar Link pending
claqu-20210630.xsd Edgar Link pending
claqu-20210630_cal.xml Edgar Link unprocessable
claqu-20210630_def.xml Edgar Link unprocessable
claqu-20210630_lab.xml Edgar Link unprocessable
claqu-20210630_pre.xml Edgar Link unprocessable
f10q0621ex31-1_cleantech.htm Edgar Link pending
f10q0621ex31-2_cleantech.htm Edgar Link pending
f10q0621ex32-1_cleantech.htm Edgar Link pending
f10q0621ex32-2_cleantech.htm Edgar Link pending
f10q0621_cleantechacq.htm Edgar Link pending
f10q0621_cleantechacq_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending